Results 41 to 50 of about 1,726 (212)

EXTRA-CORPOREAL PHOTOCHEMOTHERAPY IN THE TREATMENT OF LYMPHOMATOID PAPULOSIS AND FOLLICULOTROPIC MYCOSIS FUNGOIDES: CASE REPORTS

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Aim: To assess clinical efficacy of extra-corporeal photochemotherapy (EPCT) in the treatment of rare lymphomas  – lymphomatoid papulosis and folliculotropic mycosis fungoides.
A. V. Kil’dyushevskiy   +2 more
doaj   +1 more source

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA) [PDF]

open access: yes, 2022
Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity after allogeneic stem cell transplantation. Though perfect response rates are not achieved, steroids are still the first-line treat-ment.
Aksu, Salih   +6 more
core   +2 more sources

CLINICAL SIGNIFICANCE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN COMPLEX TREATMENT OF LOCALIZED SCLERODERMA

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Background: Scleroderma is an autoimmune disease with progressing lesions of connective tissue where fibrosclerotic and vascular disturbances prevail.
O. A. Fomina   +2 more
doaj   +1 more source

Efficacy of Narrowband UVB vs. PUVA in Patients with Early-Stage Mycosis Fungoides [PDF]

open access: yes, 2010
INTRODUCTION: Mycosis fungoides (MF) is a non-Hodgkin's T-cell lymphoma of the skin that often begins as limited patches and plaques with slow progression to systemic involvement.
Apetato, M, Ponte, P, Serrão, V
core   +1 more source

Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing [PDF]

open access: yes, 2016
Psoralen and ultraviolet A light (PUNTA) are used to kill pathogens in blood products and as a treatment of aberrant cell proliferation in dermatitis, cutaneous T-cell lymphoma, and graft versus-host disease.
Compernolle, Veerle   +7 more
core   +2 more sources

European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. [PDF]

open access: yes, 2020
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as ...
Arenberger, P.   +27 more
core   +3 more sources

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature [PDF]

open access: yes, 2007
BACKGROUND: Eosinophilic fasciitis is a rare scleroderma-like illness. The clinical spectrum of the disease has evolved since its initial description. METHODS: We identified all patients diagnosed with eosinophilic fasciitis over the past 10 years at our
Bischoff, Lindsay, Derk, Chris T
core   +2 more sources

CHANGES IN TUMOR NECROSIS FACTOR ALFA DURING TREATMENT OF PATIENTS WITH MULTIPLE SCLEROSIS BY TRANSIMMUNIZATION METHOD

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
Background: Despite the availability of a  large number of treatments for multiple sclerosis with various targets, these treatments are not always effective.
A. V. Kil'dyushevskiy   +3 more
doaj   +1 more source

Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis [PDF]

open access: yes, 2011
The optimal therapy for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) is undefined. We studied patients with SR aGVHD, comparing extracorporeal photopheresis (ECP; n = 57) and anticytokine therapy (n = 41). In multivariate analyses, ECP,
Madan Jagasia   +29 more
core   +1 more source

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease [PDF]

open access: yes, 2017
Although significant advances have been made in the biologic understanding of graft-versus-host disease (GVHD) and its treatment options, GVHD remains the single most challenging obstacle to the success of allogeneic hematopoietic cell transplantation ...
Kharfan-Dabaja, Mohamed   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy